PERFUSION-RELATED FACTORS OF ENDOTOXIN RELEASE DURING CARDIOPULMONARY BYPASS

被引:42
作者
JANSEN, PGM
VELTHUIS, HT
OUDEMANSVANSTRAATEN, HM
BULDER, ER
VANDEVENTER, SJH
STURK, A
EIJSMAN, L
WILDEVUUR, CRH
机构
[1] Department of Cardiac Surgery, Cardiopulmonary Surgical Center Amsterdam, Free University Hospital, Amsterdam, NL-1081
关键词
CARDIOPULMONARY BYPASS; ENDOTOXIN RELEASE; ONCOTIC PRESSURE; VASOCONSTRICTION; INFLAMMATORY RESPONSE;
D O I
10.1016/1010-7940(94)90167-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate whether the release of endotoxin during cardiopulmonary bypass (CPB) is determined by perfusion-related factors, endotoxin concentrations were determined before, during, and after CPB in 21 male patients (age range 45-75 years) undergoing elective coronary artery bypass grafting. Hemodynamic parameters and oncotic pressure were also measured. Significant increases in endotoxin concentrations were observed after the start of CPB (P < 0.005), before aortic cross-clamp release (P < 0.05), and after aortic cross-clamp release (P < 0.05). The median endotoxin concentration after cessation of CPB was 0.264 EU/ml (range <0.036-0.480 EU/ml). Endotoxin concentrations derived from the prime solutions were not contributory. Positive correlations were found between arterial pressure after the start of CPB and the endotoxin concentration 10 min later (r = 0.58, P < 0.01) and between the duration of aortic cross-clamping and the endotoxin concentration after the cessation of CPB (r = 0.64, P < 0.005). Arterial pressure after the start of CPB, the duration of aortic cross-clamping, and decrease in oncotic pressure appeared to be independent variables in a forward variable selection model that predicted endotoxin concentrations after CPB. We conclude that in patients undergoing elective coronary artery bypass grafting, an early phase of endotoxin release during CPB could be demonstrated, and that this is due to vasoconstriction. The endotoxin concentrations after the cessation of CPB were determined by early vasoconstriction, duration of aortic cross-clamping, and hypo-oncotic hemodilution.
引用
收藏
页码:125 / 129
页数:5
相关论文
共 23 条
[1]  
Andersen L.W., Baek L., Degn H., Lehd J., Krasnuk M., Rasmussen J.P., Presence of circulating endotoxins during cardiac operations, J Thorac Cardiovasc Surg, 93, pp. 115-119, (1987)
[2]  
Andersen L.W., Landow L., Baek L., Jansen E., Baker S., Association between gastric intramucosal pH and splanchnic endotoxin, and tumor necrosis factor-a concentrations in patients undergoing cardiopulmonary bypass, Crit Care Med, 21, 2, pp. 210-217, (1993)
[3]  
Beattie H.W., Evans G., Garnett E.S., Webber C.E., Sustained hypovolemia and extracellular fluid volume expansion following cardiopulmonary bypass, Surgery, 71, 6, pp. 891-897, (1972)
[4]  
Beattie H.W., Evans G., Garnett E.S., Regoezci E., Webber C.E., Wong K.-L., Albumin snd wutcr fluxus during curdiopul- monary bypass, J Thorac Cardiovasc Surg, 67, 6, pp. 926-931, (1974)
[5]  
Butler J., Rocker G.M., Westaby S., Inflammatory response to cardiopulmonary bypass, Ann Thorac Surg, 55, pp. 552-559, (1993)
[6]  
Chenoweth D.E., Cooper S.W., Hugli T.E., Stewart R.W., Black-Stone E.H., Kirklin J.W., Complement activation during cardiopulmonary bypass: Evidence for generation of C3a and C5a anaphylatoxins, N Engl J Med, 304, pp. 497-503, (1981)
[7]  
D' Ambra M.N., Philbin D.M., Colloids should not be added to the pump prime, J Cardiothorac Vase Anest, 4, 3, pp. 406-408, (1990)
[8]  
Deventer Van S., Biiller H.R., Cate Ten J.W., Aarden L.A., Hack C.E., Sturk A., Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic and complement pathways, Blood, 76, 12, pp. 2520-2526, (1990)
[9]  
Downing S.W., Edmunds L.H., Release of vasoactive sub-stances during cardiopulmonary bypass, An Thorac Surg, 54, pp. 1236-1243, (1992)
[10]  
Fiddian-Green R.G., Assessment of the adequacy of mucosal oxygenation in patients with intraluminally located silicone tonometers, Microcirculation in Circulatory Disorders, pp. 481-487, (1989)